S. Vadakke Puthiyottil, A. Edayattil, and S. N K, “Pathologic Response to Neoadjuvant Subcutaneous Fixed-Dose Pertuzumab–Trastuzumab (Phesgo®) and Chemotherapy in HER2-Positive Locally Advanced Breast Cancer: A Case Series and Literature Review”, apjcc, vol. 11, no. 3, pp. 481-488, May 2026.